医渡科技(02158)今日盘中股价大涨7.88%,报8.68港元,引发市场高度关注。
消息面上,知名投行花旗近日发布研究报告,对医渡科技给予"买入"评级,并将其目标价从8港元上调至12港元。花旗对其前景保持乐观态度,看好该公司在AI医疗及大数据分析等领域的潜力和成长空间,成为推动股价上涨的一大利好因素。
另一方面,南向资金也持续加码布局医渡科技。数据显示,2月17日港股通净买入医渡科技21.44万股,已连续3日保持增持态势。资金持续流入为该股注入活跃资金,也对于股价走势构成支撑。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.